Lumateperone-d4
Lumateperone-d4 (ITI-007-d4) is deuterium labeled Lumateperone. Lumateperone (ITI-007) is an orally active 5-HT2A receptor antagonist (Ki = 0.54 nM), a partial agonist of presynaptic D2 receptors and an antagonist of postsynaptic D2 receptors (Ki = 32 nM), and a dopamine D1 receptor modulator. Lumateperone has anticancer activity and can also be used for the study of schizophrenia and bipolar depression[1][2][3].
Product Specifications
CAS Number
2102683-55-4
Product Name Alternative
ITI-007-d4
UNSPSC
12352005
Target
5-HT Receptor; Dopamine Receptor; Isotope-Labeled Compounds
Related Pathways
GPCR/G Protein; Neuronal Signaling; Others
Applications
Cancer-programmed cell death
Field of Research
Cancer; Neurological Disease
Smiles
CN1C2=C3C([C@@]4([H])[C@@](CCN(C4)CCCC(C5=CC=C(C=C5)F)=O)([H])N3C([2H])([2H])C1([2H])[2H])=CC=C2
Molecular Formula
C24H24D4FN3O
Molecular Weight
397.52
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Isoform
5-HT2 Receptor
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
SARS-CoV-2 B.1.1.529 (Omicron) Spike S1 Protein
SARS-CoV-2 B.1.1.529 (Omicron) Spike S1 Protein
